Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506

10 Feb 2012

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to SARS-CoV-2 and COVID-19 Research
Share to Signaling Pathways in Disease
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 22349148
DOI: 10.1016/j.virusres.2012.02.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506PMID 22349148Read ↗

Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including AlisporivirSemantic proximity Read ↗

Nucleoside analogues for the treatment of coronavirus infectionsSemantic proximity Read ↗

Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2Semantic proximity Read ↗

Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2Semantic proximity Read ↗

The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoproteinSemantic proximity Read ↗

The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoproteinSemantic proximity Read ↗

Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell linesSemantic proximity Read ↗

Efavirenz: What is known about the cellular mechanisms responsible for its adverse effectsSemantic proximity Read ↗

Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagySemantic proximity Read ↗

The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replicationSemantic proximity Read ↗

Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variantsSemantic proximity Read ↗

ATP1A1-Mediated Src Signaling Inhibits Coronavirus Entry into Host CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.